SciClone Pharmaceuticals (Holdings) Limited (6600.HK)
HKSE - HKSE Delayed Price. Currency in HKD
Add to watchlist
At close: 04:08PM HKT
| Previous Close | 18.560 |
| Open | 18.700 |
| Bid | 18.720 x N/A |
| Ask | 18.740 x N/A |
| Day's Range | 18.680 - 18.720 |
| 52 Week Range | 8.750 - 18.720 |
| Volume | |
| Avg. Volume | 4,726,705 |
| Market Cap | 11.799B |
| Beta (5Y Monthly) | 0.77 |
| PE Ratio (TTM) | 10.12 |
| EPS (TTM) | 1.850 |
| Earnings Date | Mar 28, 2024 |
| Forward Dividend & Yield | 0.39 (2.11%) |
| Ex-Dividend Date | Jun 02, 2023 |
| 1y Target Est | 17.94 |
Business WireMenarini Group and SciClone Pharmaceuticals Announce Exclusive Sub-Licensing Collaboration to Develop and Commercialize ORSERDU® (Elacestrant) in China to Address Advanced or Metastatic Breast Cancer
FLORENCE, Italy & HONG KONG, November 07, 2023--The Menarini Group ("Menarini"), a leading international pharmaceutical and diagnostics company, and SciClone Pharmaceuticals (Holdings) Ltd. ("SciClone"), an international biopharmaceutical company, today announced that they have entered into an exclusive sub-licensing agreement to develop and commercialize ORSERDU® (elacestrant) in the People’s Republic of China (China), in an effort to expand treatment options for appropriate metastatic breast c
© 2024 Yahoo. All rights reserved.